Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $145000.0.

  • Palisade Bio's Non-Current Assets fell 6888.41% to $145000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 5586.26%. This contributed to the annual value of $386000.0 for FY2024, which is 4668.51% down from last year.
  • As of Q3 2025, Palisade Bio's Non-Current Assets stood at $145000.0, which was down 6888.41% from $220000.0 recorded in Q2 2025.
  • In the past 5 years, Palisade Bio's Non-Current Assets ranged from a high of $1.1 million in Q3 2022 and a low of $92000.0 during Q1 2022
  • In the last 5 years, Palisade Bio's Non-Current Assets had a median value of $428500.0 in 2022 and averaged $514518.0.
  • Its Non-Current Assets has fluctuated over the past 5 years, first plummeted by 8223.47% in 2021, then surged by 93586.96% in 2023.
  • Over the past 5 years, Palisade Bio's Non-Current Assets (Quarter) stood at $182000.0 in 2021, then surged by 465.93% to $1.0 million in 2022, then fell by 29.71% to $724000.0 in 2023, then plummeted by 46.69% to $386000.0 in 2024, then tumbled by 62.44% to $145000.0 in 2025.
  • Its last three reported values are $145000.0 in Q3 2025, $220000.0 for Q2 2025, and $303000.0 during Q1 2025.